Home > Reports > Treatment Planning Systems And Advanced Image Processing Market Share, Report to 2030

Treatment Planning Systems And Advanced Image Processing Market

Treatment Planning Systems And Advanced Image Processing Market: Information by Components (Treatment Planning Software), Technique (3D Image Reconstruction), and Region — Forecast till 2030

Published At : 29 Jul, 2022
Updated At : 30 Jul, 2022
Table of Content Download Sample

Market Snapshot

Base Year:
2021
Study Period:
2020-2030
CAGR:
8.18 %
Fastest Growing Market:
Asia Pacific
Largest Market:
North America

The global treatment planning systems and advanced image processing market size was valued at USD 1.68 billion in 2021 and is projected to reach USD 3.40 billion by 2030 at a CAGR of 8.18% from 2022 to 2030. The rising incidence of cancer around the world necessitates the development of innovative and effective cancer treatment techniques. The growth of the planning systems and advanced image processing market is fueled by the emergence of the healthcare IT industry and its supporting infrastructure, soaring investments in cancer care segments, and rising demand for advanced solutions. In 2020, an estimated 19.3 million new cases of cancer are anticipated to be diagnosed worldwide. China alone was responsible for 24% of cancer cases in 2020, while the United States had a significantly higher number of approximately 1.8 million patients diagnosed with cancer that same year. The increase in occurrences necessitates the development of novel treatments.

Get more information on this report Download Sample Report

Market Dynamics

Market Drivers for the Treatment Planning Systems And Advanced Image Processing Market

  • Rising Mortalities Due To Cancer Are Driving The Market

The global market will be primarily driven by factors such as the worldwide increase in cancer cases and the adoption of innovative technologies such as artificial intelligence for cancer treatment. During the forecast period, the increasing use of radiotherapy and the adoption of software systems for treatment planning are anticipated to fuel the growth of planning systems and the advanced image processing market.

Due to the high mortality rate associated with cancer, new treatment procedures are being developed to reduce cancer-related fatalities. Nearly fifty percent of cancer patients receive radiotherapy, making it one of the most important forms of treatment. Due to the expanding use of radiotherapy, the number of advanced radiotherapy centers is expanding worldwide.

There are approximately 2,332 radiotherapy centers in the United States alone, and it is anticipated that there will be 4,1 million radiotherapy survivors in the world by 2030. All of these necessitate innovative treatment planning solutions and advanced image processing systems, which will increase the market growth for planning systems and advanced image processing systems over the next few years.

  • The Growing Popularity Of Radiotherapy Is Driving The Market

The increasing prevalence of radiotherapy for the diagnosis and treatment of cancer is one of the major factors driving the expansion of the treatment planning systems and advanced image processing markets. According to an article published by the American Cancer Society in June 2019, nearly half (49%) of early-stage breast cancer patients undergo Breast-conserving Surgery (BCS) with adjuvant radiation therapy for treatment due to its increased efficacy. In addition, several government initiatives to develop a modern healthcare infrastructure for the diagnosis by oncology utilizing advanced medical imaging technology are expected to accelerate market growth over the coming years. Instituto Mexicano del Seguro Social is Mexico's largest public health care provider. In April 2018, Elekta received approval from the Mexican government to provide sophisticated radiation therapy equipment and software to this organization (IMSS).

Restraints For The Treatment Planning Systems And Advanced Image Processing Market

  • High Costs And Lowers Adoption Rates Act As Major Restraints For The Market

The higher cost involved in the treatment planning software, less adoption rate in developing countries, and lack of skilled workforce to operate and plan the treatment using the software is restricting the development of the Treatment Planning Systems And Advanced Image Processing Market.

Opportunities For The Treatment Planning Systems And Advanced Image Processing Market

  • Latest Technologies Are Bringing In Newer Opportunities

The increasing adoption of artificial intelligence and machine learning by market participants in the development of oncology software solutions to improve treatment plans, cancer diagnosis, and cancer management is contributing to the expansion of the treatment planning systems and advanced image processing market. Increasing initiatives and projects to develop health information learning platforms to support improved quality of care for oncology are also expected to stimulate market growth. As of March 2020, for instance, CancerLinQ, a big-data platform for oncology developed by CancerLinQ LLC, contained the data of 1,426,015 cancer patients from 63organizationss in the United States. Similarly, in May 2019, the new American College of Radiology Data Science Institute (ACR DSI) launched AI-LAB, a free software platform that allows radiologists to participate in the creation of validation and the use of artificial intelligence (AI) in health care.

 

Segmental Insights

This market can be segmented on the basis of components, technique, application, region, and competitors. In 2021, 88.1% of all revenue was generated by the treatment planning software segment. This high segment share is a result of the increasing prevalence of cancer and the rising demand for precise and innovative oncology therapy solutions. Increasing awareness regarding the adoption of treatment planning software solutions as a result of their efficacy in radiotherapy-based cancer treatment is also driving the segment's expansion. In addition, advancements in healthcare infrastructure, an increase in public-private partnerships, and a preference for software solutions over conventional practice are significant contributors to the segment's high revenue share.

In addition, the auto-contouring software subsegment of treatment planning software solutions held the largest market share in 2021, at 31,1%. Manual contouring lacks efficiency, precision, and standardization, limiting its adoption and increasing the demand for auto-contouring solutions for radiotherapy. In addition, the segment's growth is also influenced by an increase in product launches. In May of 2020, for instance, Mirada Medical released the online version of the auto-contouring software 'DLCExpert' for the treatment of cancer during the COVID-19 pandemic.

55.4% of 2021's total revenue was generated by the in-room imaging segment. One of the major contributors to the segment's high market share is the increasing technological sophistication of cancer-treating radiology procedures that provide real-time image data. There is a growing demand for in-room imaging processes in order to provide precise and accurate treatment options. This procedure involves capturing images during therapy and sharing them with radiologists in order to overcome obstacles such as tissue radiotherapy toxicity and dosage standardization.

In 2021, the segment of image registration validation generated the greatest percentage of revenue, 27.4%. This proportion of the market is attributable to the significance of image dataset creation and registration in the treatment planning procedure. The medical image registration generates real-time image datasets from anatomical atlases and multiple image modalities to facilitate accurate and efficient dose planning. During cancer therapy, these solutions conduct validations on dosage accumulation, dose distribution, and contours using imaged datasets. Varian Medical Systems and RaySearch Laboratories are the two leading developers of platforms for validating image registration.

 

Regional Insights

Treatment Planning Systems And Advanced Image Processing Market Regional Analysis

Regional Growth Insights Request Sample Pages

In 2021, 38.5% of the global treatment planning systems and advanced image processing market revenue was generated in North America. This portion of the region can be attributed to the expansion of healthcare IT infrastructure and the rapid adoption of advanced image processing and treatment planning solutions. In addition, the presence of advanced cancer research institutes and improved healthcare infrastructure are the primary factors driving the market in this region. North America's market for treatment planning systems and advanced image processing is expanding as a result of the rising demand for advanced, precise, and effective cancer treatment techniques.

However, in Asia-Pacific, the market for treatment planning systems and advanced image processing is expected to grow at a high CAGR over the forecast period due to the widespread adoption of healthcare IT solutions and constant advancements in healthcare in many developing economies such as India and China. The rising incidence of cancer and rising healthcare expenditures by both private and public players are fostering market expansion. For instance, Globocan 2020 estimates that in the Asia-Pacific region, there will be approximately 9,503,710 new cancer cases. In addition, initiatives by the government and private organizations to raise awareness and accelerate the adoption of advanced image processing solutions for cancer treatment are expected to drive market growth over the forecast period.

 

Competitive Landscape

List of Key Companies Profiled in Treatment Planning Systems And Advanced Image Processing Market

  • DOSIsoft SA
  • Koninklijke Philips N.V.
  • MIM Software Inc.
  • RaySearch Laboratories
  • Elekta AB
  • Brainlab AG
  • IBA Worldwide
  • Accuray Incorporated
  • VIEWRAY TECHNOLOGIES INC.
  • Varian Medical Systems Inc.
  • Institut Straumann AG
  • Nobel Biocare Services AG
  • CAMLOG Biotechnologies AG
  • medentis medical GmbH
  • BEGO Medical GmbH
  • Dentsply Sirona.
  • Zimmer Biomet
  • Sweden & Martina S.p.A.
  • MIS IMPLANTS TECHNOLOGIES LTD.
  • 3D Diagnostix
  • 3DIEMME srl
  • ACE Surgical Supply Co.
  • Alpha-Bio Tec Ltd.
  • Blue Sky Bio
  • Biocon
  • Thommen Medical AG

 

Recent Developments

  • Fujitsu collaborated with University of Toronto researchers in February 2021 to develop technology to streamline radiation treatment plans for brain tumors and arteriovenous malformations.
  • During the COVID-19 pandemic, Mirada Medical released the online version of the auto-contouring software DLCExpert for the treatment of cancer in May 2020.
  • In January of 2021, OncoLens secured USD 7.3 million in Series A funding. In addition, General Atlantic contributed approximately USD 200 million to the launch of OneOncology, a company designed to assist community oncology practices with technical data, innovation, and research.
  • Accuray Inc. and Brainlab collaborated in October 2020 on the expansion of the Accuray CyberKnife treatment platform to improve patient outcomes in neuro-radiosurgery.
  • By educating oncology practices, ViewRay Inc. and VieCure, an AI-based informatics company, collaborated in April 2020 to promote personalized cancer care.

 

Treatment Planning Systems And Advanced Image Processing Market: Segmentation

By Components

  • Advanced Image Processing Software
  • Treatment Planning Software
    • Auto-Contouring Software
    • Multi-Modality Software
    • PET/CT Deformable Software
    • DICOM-RT Software

By Technique

  • 3D Image Reconstruction
  • In-Room Imaging
  • Image Registration using Graphics Processor Unit

By Application

  • Adaptive Radiotherapy
  • Online Monitoring
  • Tracking
  • Dose Accumulation
  • Validation of Image Registration

By Region

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa
Free Sample Report

"Find new revenue generation opportunities"